Results

Total Results: 2,142 records

Showing results for "response".

181. Sas-Macro-Plain-Text-Version
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sas-macro-plain-text-version.txt
     December 05, 2017 - under MODEL */ /* with each treatment group modeled separately */ /* create _wgts0_ and _wgts1_ were response … variable to 1 */ %let iv=1; /* get the model */ %let outmod=%qscan(&model,1,/); /* get the response … not selected then */ /* extract the model OUTMOD */ %else %do; %let outmod=&model; /* get the response … )=_foo1_ then do; tt=put(type,8.); call symput('exptype',tt); end; run; /* get the type of response … variable __RES01 in the data set */ /* get the values of the response variable */ /* if the response

182. EPC Response to IOM Standards for Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/iom-standards/white-paper
     April 10, 2013 - EPC Response to IOM Standards for Systematic Reviews White Paper April 10, 2013 Web Version [NLM Site … Conclusions/Recommendations This process engaged the EPCs in a productive, collaborative evaluation and response

183. Major-Depressive-Disorder Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
     December 01, 2015 - with depression that is harder to treat, as evidenced by more difficulty in achieving treatment response … Inclusion/exclusion criteria (continued) Criteria Inclusion Exclusion Outcomes • Benefits: response … to treatment, remission, speed of response, speed of remission, relapse, quality of life, functional … Our outcome measure of choice was the rate of response on the Hamilton Depression Rating Scale 6 … Adding CBT to SGA did not show any benefit in remission or response, as defined previously, and led

184. Research Review Title: Infection Prevention and Control for the Emergency Medical Services and 911 Workforce (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
     November 01, 2022 - workforce-infection-control/report Published Online: November 1, 2022 2 Summary of Peer Reviewer Comments and Author Response … workforce-infection-control/report Published Online: November 1, 2022 3 Public Comments and Author Response … Commentator & Affiliation Section Comment Response NASEMSO ES-1 Executive Summary ES-1 … workforce-infection-control/report Published Online: November 1, 2022 4 Commentator & Affiliation Section Comment Response … (response above) Aubrey Brown Executive Summary, Results, paragraph 4 One study demonstrated that

185. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/Disposition%20of%20Comments.pdf
     September 03, 2019 - In response we have included the following points in the Discussion on page 146: “Symptom reporting … For example, as noted in our response to Comment #10, studies are heterogeneous enough in exposure … Nonetheless, some response to this, or commentary on what has been reported in other studies may be … It is unclear to me what low and medium mean, so perhaps a footnote describing response options and … In response to this reviewer we have added text to provide context regarding the consistency and strength

186. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Disposition%20of%20Comments.pdf
     September 03, 2019 - In response we have included the following points in the Discussion on page 146: “Symptom reporting … For example, as noted in our response to Comment #10, studies are heterogeneous enough in exposure … Nonetheless, some response to this, or commentary on what has been reported in other studies may be … It is unclear to me what low and medium mean, so perhaps a footnote describing response options and … In response to this reviewer we have added text to provide context regarding the consistency and strength

187. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
     September 03, 2019 - In response we have included the following points in the Discussion on page 146: “Symptom reporting … For example, as noted in our response to Comment #10, studies are heterogeneous enough in exposure … Nonetheless, some response to this, or commentary on what has been reported in other studies may be … It is unclear to me what low and medium mean, so perhaps a footnote describing response options and … In response to this reviewer we have added text to provide context regarding the consistency and strength

188. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - The evidence is insufficient to determine factors that can reliably predict response or nonresponse in … • Sertraline versus venlafaxine (3 studies; 470 patients): Pooled response rates were similar for … The strength of evidence is moderate. 6 Speed of Response Seven studies, all of fair quality and … Response to Antidepressant Agents After Successful Response in the Past (KQ 1b) We did not find any … Low One trial reported higher response rates for venlafaxine XR than venlafaxine IR.

189. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - ACR50 response rates were 36%, 69%, and 87% respectively (p= .0001 and .03, respectively). … A new meta-analysis9 found PsA Response Criteria (PsARC) response at 12-14 weeks was significantly … ACR20 response at 12-16 weeks was greater for both anti-TNFs and other biologics. … Psoriasis area and severity index (PASI) response was greater the FDA in October, 2012. … ACR50 response rates were Did not conduct statistical tests on adverse events data.

190. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - displayproduct&productID=1860 Published Online: February 11, 2014 1 Commentator Section Comments Response … This whole document was prepared through the narrow lens of a methodological response to the wrong … I think that if you use studies whose duration is 12 months or less you should consider them dose response … Also, no mention is made of the genetic variations in response to statins and that perhaps one should … Further, we did not examine differences in statin response based on genetic variations PCSK-9 is

191. Data-Points-6-Maps (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-maps.pdf
     August 22, 2011 - Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service … Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service … Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service … Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service

192. Disposition of Comments: Comparative Effectiveness Review No. 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-episodic-migraine-comments.pdf
     December 29, 2020 - www.effectivehealthcare.ahrq.gov/reports/final.cfm Summary of Public Reviewer Comments and Author Response … research Published Online: December 29, 2020 3 : Commentator & Affiliation Section Comment Response … migraine-treatments/research Published Online: December 29, 2020 4 Commentator & Affiliation Section Comment Response … migraine-treatments/research Published Online: December 29, 2020 5 Commentator & Affiliation Section Comment Response

193. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Results indicated better sustained virologic response associated with the study drug. … Sustained virological response •! … Dual therapy with Pegylated Interferon Alfa-2a plus Ribavirin Outcome: Sustained viroligic response … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided

194. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Results indicated better sustained virologic response associated with the study drug. … Sustained virological response •! … Dual therapy with Pegylated Interferon Alfa-2a plus Ribavirin Outcome: Sustained viroligic response … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided … Alfa-2b and Duration effects Outcome: Sustained viroligic response SOE: Low 1 trial of response-guided

195. Disposition of Comments Report for Outpatient Case Management for Adults With Medical Illness and Complex Care Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_disposition-comments.pdf
     January 01, 2013 - www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 2 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 3 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 4 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 5 Commentator & Affiliation Section Comment Response … www.effectivehealthcare.ahrq.gov Published Online: Month XX, 20XX 6 Commentator & Affiliation Section Comment Response

196. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - (NOTE: See also response to comment #16, below). … Rodondi and ask him; awaiting a response. … Thank you – no response required Peer Reviewer #12 Results The results section is complete. … Thank you – no response required Peer Reviewer #12 Clarity and Usability It would be helpful … See response to comment #96.

197. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-disposition-comments.pdf
     April 23, 2019 - osteoporosis-fracture-prevention/research Published Online: April 23, 2019 2 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 3 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 4 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 5 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 6 Section Commentator & Affiliation Comment Response

198. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
     April 23, 2019 - osteoporosis-fracture-prevention/research Published Online: April 23, 2019 2 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 3 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 4 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 5 Section Commentator & Affiliation Comment Response … osteoporosis-fracture-prevention/research Published Online: April 23, 2019 6 Section Commentator & Affiliation Comment Response

199. Strategies to De-escalate Aggressive Behavior in Psychiatric Patients (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_disposition-comments.pdf
     July 14, 2016 - productid=2256 Published Online: July 14, 2016 2 Section Commentator and Affiliation Comment Response … productid=2256 Published Online: July 14, 2016 3 Section Commentator and Affiliation Comment Response … productid=2256 Published Online: July 14, 2016 4 Section Commentator and Affiliation Comment Response … productid=2256 Published Online: July 14, 2016 5 Section Commentator and Affiliation Comment Response … Too many studies of agitation/aggression have focused solely on reduction of level of agitation response

200. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - Peer Reviewer #2 Results There clearly are trials that show a dose response for dopamine agonists … All of the numerous statements about lack of dose response need to be eliminated. … The authors somehow state response is not a dose response. … Public Comment Results Long-Term Harms/Withdrawal from Treatment – please see enclosed response … Reviewer #8 Kimberly Moran, PhD Medical Director, CNS UCB Placebo Response We agree with